A continuous study to identify the distinct mechanism of cell death mediated by the CLK inhibitor as well as its key downstream targets may demonstrate the mechanism underlying MYC induction‐mediated cancer cell vulnerability to CLK inhibition. This evidence concerns the gene CLK1 and cancer.